Peripheral Intervention Drug-Eluting Devices Market 2027 By Product, Application, End User and Geography | The Insight Partners

Peripheral Intervention Drug-Eluting Devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Drug-eluting Balloons, Drug-eluting Stents); Application (Plain Old Balloon Angioplasty (POBA), Percutaneous Transluminal Angioplasty (PTA)); End User (Hospitals, Catheterization Laboratories, Ambulatory Surgical Centers, Others) and Geography

Report Code: TIPRE00017464 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Covid
MARKET INTRODUCTION

Peripheral intervention drug-eluting devices include stents and balloons. Due to their non-invasive nature, peripheral intervention drug-eluting devices provide greater treatment efficiency, thus assisting in managing cardiovascular diseases over the period. The drug-eluting stent (DES) is peripheral or coronary is placed into narrowed, affected coronary or peripheral arteries that very slowly release a drug to inhibit cell proliferation. This prevents fibrosis that, together with clots, could otherwise block the stented artery, a restenosis process. On the other hand, the drug-eluting balloon catheter is an advanced medical device that has shown remarkable efficiency in carrying out the procedures. Multiple companies are now shifting towards the manufacturing of drug-eluting balloon catheters since they are proving to be much more effective as compared to stenting or balloon angioplasty. Also, a drug-eluting balloon catheter can help treat patients who do not benefit from percutaneous coronary intervention (PCI).

MARKET DYNAMICS

The peripheral intervention drug-eluting devices market has shown a significant evolution over the forecast period. The rise of the peripheral intervention drug-eluting devices market is majorly driven by the increasing number of patients with cardiovascular ailments and the surging rate of cardiology intervention procedures. According to the CDC (Centre for Disease Control), approximately 8.5 million people in the U.S. suffer from PAD (Peripheral Artery Disease), including 12-20% of individuals older than 60 years of age. This rising prevalence of peripheral artery diseases and increasing healthcare expenditure in lower-middle-income countries is expected to boost the growth of the global peripheral intervention drug-eluting devices market over the forecast period. Manufacturers are trying to develop low-cost devices, which will further expand its adoption over the next couple of years. Moreover, improved reimbursement support, increasing healthcare expenditure, and growing geriatric population are some of the other additional factors likely to influence the market's growth. However, the occurrence of stent thrombosis is expected to restrain the market growth.

MARKET SCOPE

The "Peripheral Intervention Drug-Eluting Devices Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry's medical device, with a specific focus on the global market trend analysis. This report provides an outline of the peripheral intervention drug-eluting devices market with detailed market segmentation by product, application, and end-user. The peripheral intervention drug-eluting devices market is estimated to witness high growth during the forecast period. It focuses on the vital statistics on the leading players' market status in the peripheral intervention drug-eluting devices market and offers key opportunities and trends in the market.

MARKET SEGMENTATION

The market is categorized based on the product, application, and end user. Based on the product, the market is segmented as drug-eluting balloons and drug-eluting stents. Based on the application, the segmentation of the market is into plain old balloon angioplasty (POBA) and percutaneous transluminal angioplasty (PTA). Based on end user, segmentation of the market is into hospitals, catheterization laboratories, ambulatory surgical centers, and others.

REGIONAL FRAMEWORK

The report states a detailed outline of the industry, consisting of both qualitative and quantitative information. It gives a sketch and forecast of the peripheral intervention drug-eluting devices market based on various segments. The report also consists of market size and forecast estimates from the year 2018 to2027with respect to five primary regions, namely; North America, Asia-Pacific (APAC), Europe, Middle East, and Africa (MEA), and South & Central America (SCAM). The peripheral intervention drug-eluting devices market by each region is then subdivided into respective countries and segments. It offers the analysis and forecast of 18 countries worldwide and the recent trend and opportunities prevailing in the region.

The report analyzes factors affecting the peripheral intervention drug-eluting devices market from both the demand and supply sides. Furthermore, it assesses market dynamics affecting the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also comprises a precise PEST analysis for all five regions, namely, North America, APAC, Europe, MEA, and South & Central America, after evaluating political, social, economic, and technological factors affecting the peripheral intervention drug-eluting devices market in these regions.



Get more information on this report :

MARKET PLAYERS


The report contains critical developments in the peripheral intervention drug-eluting devices market as inorganic and organic growth strategies. Various companies are pivoting on organic growth strategies like product approvals, product launches, and others, such as events and patents. Inorganic growth strategies noticed in the market were acquisitions and collaborations &partnerships. Such activities have paved the path for the expansion of the business and customer base of market players. The market players from the peripheral intervention drug-eluting devices market are anticipated to have profitable growth opportunities in the following years with the increasing demand for peripheral intervention drug-eluting devices in the global market. Below mentioned is the list of a few companies engaged in the peripheral intervention drug-eluting devices market.
The report also offers key players' profiles in the peripheral intervention drug-eluting devices market, along with their SWOT analysis and market strategies. Also, the report focuses on leading market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.

  •  Abbott.
  •  BIOTRONIK SE & Co. KG
  •  Cook
  •  Cardinal Health. (Cordis)
  •  Boston Scientific Corporation
  •  C.R. Bard Inc.
  •  Medtronic
  •  Terumo Medical Corporation
  •  Meril Life Sciences Pvt. Ltd.
  •  B. Braun Melsungen AG

The Insight Partner's dedicated research and analysis team comprises of experienced professionals with advanced statistical expertise and offers various customization options in the current study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Peripheral Intervention Drug-Eluting Devices Market - By Product
1.3.2 Peripheral Intervention Drug-Eluting Devices Market - By Application
1.3.3 Peripheral Intervention Drug-Eluting Devices Market - By End User
1.3.4 Peripheral Intervention Drug-Eluting Devices Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES MARKET - GLOBAL MARKET ANALYSIS
6.1. PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES - GLOBAL MARKET OVERVIEW
6.2. PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. DRUG-ELUTING BALLOONS
7.3.1. Overview
7.3.2. Drug-eluting Balloons Market Forecast and Analysis
7.4. DRUG-ELUTING STENTS
7.4.1. Overview
7.4.2. Drug-eluting Stents Market Forecast and Analysis
8. PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. PLAIN OLD BALLOON ANGIOPLASTY (POBA)
8.3.1. Overview
8.3.2. Plain Old Balloon Angioplasty (POBA) Market Forecast and Analysis
8.4. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA)
8.4.1. Overview
8.4.2. Percutaneous Transluminal Angioplasty (PTA) Market Forecast and Analysis
9. PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CATHETERIZATION LABORATORIES
9.4.1. Overview
9.4.2. Catheterization Laboratories Market Forecast and Analysis
9.5. AMBULATORY SURGICAL CENTERS
9.5.1. Overview
9.5.2. Ambulatory Surgical Centers Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis

10. PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Peripheral Intervention Drug-Eluting Devices Market Overview
10.1.2 North America Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis
10.1.3 North America Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis - By Product
10.1.4 North America Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis - By Application
10.1.5 North America Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis - By End User
10.1.6 North America Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis - By Countries
10.1.6.1 United States Peripheral Intervention Drug-Eluting Devices Market
10.1.6.1.1 United States Peripheral Intervention Drug-Eluting Devices Market by Product
10.1.6.1.2 United States Peripheral Intervention Drug-Eluting Devices Market by Application
10.1.6.1.3 United States Peripheral Intervention Drug-Eluting Devices Market by End User
10.1.6.2 Canada Peripheral Intervention Drug-Eluting Devices Market
10.1.6.2.1 Canada Peripheral Intervention Drug-Eluting Devices Market by Product
10.1.6.2.2 Canada Peripheral Intervention Drug-Eluting Devices Market by Application
10.1.6.2.3 Canada Peripheral Intervention Drug-Eluting Devices Market by End User
10.1.6.3 Mexico Peripheral Intervention Drug-Eluting Devices Market
10.1.6.3.1 Mexico Peripheral Intervention Drug-Eluting Devices Market by Product
10.1.6.3.2 Mexico Peripheral Intervention Drug-Eluting Devices Market by Application
10.1.6.3.3 Mexico Peripheral Intervention Drug-Eluting Devices Market by End User
10.2. EUROPE
10.2.1 Europe Peripheral Intervention Drug-Eluting Devices Market Overview
10.2.2 Europe Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis
10.2.3 Europe Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis - By Product
10.2.4 Europe Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis - By Application
10.2.5 Europe Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis - By End User
10.2.6 Europe Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Peripheral Intervention Drug-Eluting Devices Market
10.2.6.1.1 Germany Peripheral Intervention Drug-Eluting Devices Market by Product
10.2.6.1.2 Germany Peripheral Intervention Drug-Eluting Devices Market by Application
10.2.6.1.3 Germany Peripheral Intervention Drug-Eluting Devices Market by End User
10.2.6.2 France Peripheral Intervention Drug-Eluting Devices Market
10.2.6.2.1 France Peripheral Intervention Drug-Eluting Devices Market by Product
10.2.6.2.2 France Peripheral Intervention Drug-Eluting Devices Market by Application
10.2.6.2.3 France Peripheral Intervention Drug-Eluting Devices Market by End User
10.2.6.3 Italy Peripheral Intervention Drug-Eluting Devices Market
10.2.6.3.1 Italy Peripheral Intervention Drug-Eluting Devices Market by Product
10.2.6.3.2 Italy Peripheral Intervention Drug-Eluting Devices Market by Application
10.2.6.3.3 Italy Peripheral Intervention Drug-Eluting Devices Market by End User
10.2.6.4 Spain Peripheral Intervention Drug-Eluting Devices Market
10.2.6.4.1 Spain Peripheral Intervention Drug-Eluting Devices Market by Product
10.2.6.4.2 Spain Peripheral Intervention Drug-Eluting Devices Market by Application
10.2.6.4.3 Spain Peripheral Intervention Drug-Eluting Devices Market by End User
10.2.6.5 United Kingdom Peripheral Intervention Drug-Eluting Devices Market
10.2.6.5.1 United Kingdom Peripheral Intervention Drug-Eluting Devices Market by Product
10.2.6.5.2 United Kingdom Peripheral Intervention Drug-Eluting Devices Market by Application
10.2.6.5.3 United Kingdom Peripheral Intervention Drug-Eluting Devices Market by End User
10.2.6.6 Rest of Europe Peripheral Intervention Drug-Eluting Devices Market
10.2.6.6.1 Rest of Europe Peripheral Intervention Drug-Eluting Devices Market by Product
10.2.6.6.2 Rest of Europe Peripheral Intervention Drug-Eluting Devices Market by Application
10.2.6.6.3 Rest of Europe Peripheral Intervention Drug-Eluting Devices Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market Overview
10.3.2 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis
10.3.3 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Peripheral Intervention Drug-Eluting Devices Market
10.3.6.1.1 Australia Peripheral Intervention Drug-Eluting Devices Market by Product
10.3.6.1.2 Australia Peripheral Intervention Drug-Eluting Devices Market by Application
10.3.6.1.3 Australia Peripheral Intervention Drug-Eluting Devices Market by End User
10.3.6.2 China Peripheral Intervention Drug-Eluting Devices Market
10.3.6.2.1 China Peripheral Intervention Drug-Eluting Devices Market by Product
10.3.6.2.2 China Peripheral Intervention Drug-Eluting Devices Market by Application
10.3.6.2.3 China Peripheral Intervention Drug-Eluting Devices Market by End User
10.3.6.3 India Peripheral Intervention Drug-Eluting Devices Market
10.3.6.3.1 India Peripheral Intervention Drug-Eluting Devices Market by Product
10.3.6.3.2 India Peripheral Intervention Drug-Eluting Devices Market by Application
10.3.6.3.3 India Peripheral Intervention Drug-Eluting Devices Market by End User
10.3.6.4 Japan Peripheral Intervention Drug-Eluting Devices Market
10.3.6.4.1 Japan Peripheral Intervention Drug-Eluting Devices Market by Product
10.3.6.4.2 Japan Peripheral Intervention Drug-Eluting Devices Market by Application
10.3.6.4.3 Japan Peripheral Intervention Drug-Eluting Devices Market by End User
10.3.6.5 South Korea Peripheral Intervention Drug-Eluting Devices Market
10.3.6.5.1 South Korea Peripheral Intervention Drug-Eluting Devices Market by Product
10.3.6.5.2 South Korea Peripheral Intervention Drug-Eluting Devices Market by Application
10.3.6.5.3 South Korea Peripheral Intervention Drug-Eluting Devices Market by End User
10.3.6.6 Rest of Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market
10.3.6.6.1 Rest of Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market by Product
10.3.6.6.2 Rest of Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market by Application
10.3.6.6.3 Rest of Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Overview
10.4.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis
10.4.3 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Peripheral Intervention Drug-Eluting Devices Market
10.4.6.1.1 South Africa Peripheral Intervention Drug-Eluting Devices Market by Product
10.4.6.1.2 South Africa Peripheral Intervention Drug-Eluting Devices Market by Application
10.4.6.1.3 South Africa Peripheral Intervention Drug-Eluting Devices Market by End User
10.4.6.2 Saudi Arabia Peripheral Intervention Drug-Eluting Devices Market
10.4.6.2.1 Saudi Arabia Peripheral Intervention Drug-Eluting Devices Market by Product
10.4.6.2.2 Saudi Arabia Peripheral Intervention Drug-Eluting Devices Market by Application
10.4.6.2.3 Saudi Arabia Peripheral Intervention Drug-Eluting Devices Market by End User
10.4.6.3 U.A.E Peripheral Intervention Drug-Eluting Devices Market
10.4.6.3.1 U.A.E Peripheral Intervention Drug-Eluting Devices Market by Product
10.4.6.3.2 U.A.E Peripheral Intervention Drug-Eluting Devices Market by Application
10.4.6.3.3 U.A.E Peripheral Intervention Drug-Eluting Devices Market by End User
10.4.6.4 Rest of Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market
10.4.6.4.1 Rest of Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market by Product
10.4.6.4.2 Rest of Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market by Application
10.4.6.4.3 Rest of Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Peripheral Intervention Drug-Eluting Devices Market Overview
10.5.2 South and Central America Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis
10.5.3 South and Central America Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis - By Product
10.5.4 South and Central America Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis - By Application
10.5.5 South and Central America Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis - By End User
10.5.6 South and Central America Peripheral Intervention Drug-Eluting Devices Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Peripheral Intervention Drug-Eluting Devices Market
10.5.6.1.1 Brazil Peripheral Intervention Drug-Eluting Devices Market by Product
10.5.6.1.2 Brazil Peripheral Intervention Drug-Eluting Devices Market by Application
10.5.6.1.3 Brazil Peripheral Intervention Drug-Eluting Devices Market by End User
10.5.6.2 Argentina Peripheral Intervention Drug-Eluting Devices Market
10.5.6.2.1 Argentina Peripheral Intervention Drug-Eluting Devices Market by Product
10.5.6.2.2 Argentina Peripheral Intervention Drug-Eluting Devices Market by Application
10.5.6.2.3 Argentina Peripheral Intervention Drug-Eluting Devices Market by End User
10.5.6.3 Rest of South and Central America Peripheral Intervention Drug-Eluting Devices Market
10.5.6.3.1 Rest of South and Central America Peripheral Intervention Drug-Eluting Devices Market by Product
10.5.6.3.2 Rest of South and Central America Peripheral Intervention Drug-Eluting Devices Market by Application
10.5.6.3.3 Rest of South and Central America Peripheral Intervention Drug-Eluting Devices Market by End User

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES MARKET, KEY COMPANY PROFILES
12.1. ABBOTT.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BIOTRONIK SE & CO. KG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. COOK
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CARDINAL HEALTH. (CORDIS)
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BOSTON SCIENTIFIC CORPORATION
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. C.R. BARD INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MEDTRONIC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. TERUMO MEDICAL CORPORATION
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MERIL LIFE SCIENCES PVT. LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. B. BRAUN MELSUNGEN AG
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott.
2. BIOTRONIK SE & Co. KG
3. Cook
4. Cardinal Health. (Cordis)
5. Boston Scientific Corporation
6. C.R. Bard Inc.
7. Medtronic
8. Terumo Medical Corporation
9. Meril Life Sciences Pvt. Ltd.
10. B. Braun Melsungen AG
TIPRE00017464
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking